Here are four insights:
1. The two new patents add to the company’s existing 22 patents, which cover all aspects of the Jazz platform.
2. The Jazz platform is designed to treat spinal pathologies requiring vertebral fusion surgery.
3. Implanet hopes to further strengthen its Jazz platform with future patents, noting the spine market is estimated at $2.1 billion.
4. CEO of Implanet Ludovic Lastennet said, “Obtaining these patents is an integral part of our value creation strategy. The systematic growth of our [intellectual property] protection enables us to reinforce our current commercial partnership and outlook towards future strategic alliances.”
More articles on devices and implants:
North America spinal implants market to hit $8.6B by 2021 — 5 observations
Spine device company earns $50k grant at pediatric innovation symposium: 5 highlights
Mazor Robotics, Stryker, Amedica & more: 17 device company notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
